Literature DB >> 8904815

Structure-activity relationships of neuromedin U. III. Contribution of two phenylalanine residues in dog neuromedin U-8 to the contractile activity.

K Kurosawa1, N Sakura, T Hashimoto.   

Abstract

Dog neuromedin U-8 (d-NMU-8; pGlu-X2-Leu-Y4-Arg-Pro-Arg-Asn-NH2, X = Y = Phe) has potent biological activity to stimulate an isolated chicken crop smooth muscle preparation with the relative activity (RA value) of 5.78 to porcine neuromedin U-8 (p-NMU-8). To elucidate the contribution of the two phenylalanine residues of NMU-8 to the biological activity, fourteen d-NMU-8 analogs modified either at position 2 or 4, [X2]- or [Y4]-d-NMU-8, were synthesized, where X and Y were Ala, Tyr, Trp, Thr, Glu, His or cyclohexylalanine (Cha). Most of the analogs retained very low contractile activity, suggesting the importance of both Phe residues in d-NMU-8 for the biological activity. [X2]-d-NMU-8 analogs had lower biological activity in terms of the RA value than the corresponding [Y4]-d-NMU-8, when X and Y are the same amino acid. Loss of aromaticity of Phe2 ([Cha2]-d-NMU-8) resulted in a marked decrease of the contractile activity, while that of Phe4 ([Cha4]-d-NMU-8) resulted in retention of considerable activity, with the RA value of 2.68. [Tyr4]-d-NMU-8 was an exceptional analog with higher contractile activity (p < 0.01) than the parent compound d-NMU-8, having the RA value of 12.6. The results indicated that the aromatic side chain of the Phe residue at position 2 contributes more than that at position 4 to the biological activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8904815     DOI: 10.1248/cpb.44.1880

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

1.  Discovery of potent hexapeptide agonists to human neuromedin u receptor 1 and identification of their serum metabolites.

Authors:  Kentaro Takayama; Kenji Mori; Yuko Sohma; Koji Taketa; Akihiro Taguchi; Fumika Yakushiji; Naoto Minamino; Mikiya Miyazato; Kenji Kangawa; Yoshio Hayashi
Journal:  ACS Med Chem Lett       Date:  2015-01-28       Impact factor: 4.345

2.  Small lipidated anti-obesity compounds derived from neuromedin U.

Authors:  Ewa D Micewicz; Omar S O Bahattab; Gary B Willars; Alan J Waring; Mohamad Navab; Julian P Whitelegge; William H McBride; Piotr Ruchala
Journal:  Eur J Med Chem       Date:  2015-07-14       Impact factor: 6.514

3.  A Zebrafish Genetic Screen Identifies Neuromedin U as a Regulator of Sleep/Wake States.

Authors:  Cindy N Chiu; Jason Rihel; Daniel A Lee; Chanpreet Singh; Eric A Mosser; Shijia Chen; Viveca Sapin; Uyen Pham; Jae Engle; Brett J Niles; Christin J Montz; Sridhara Chakravarthy; Steven Zimmerman; Kourosh Salehi-Ashtiani; Marc Vidal; Alexander F Schier; David A Prober
Journal:  Neuron       Date:  2016-02-17       Impact factor: 17.173

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.